We are monitoring the impact of COVID-19 & Recession alarm on North America Nucleic Acid Labelling Market Get in touch with us for detailed analysis Know More
Share on

North America Nucleic Acid Labelling Market Research Report – Segmented By Product, Labelling Technique, Application, End User & Country (The United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2809
Pages: 145

North America Nucleic Acid Labelling Market Size (2022 to 2027)

The Nucleic Acid Labelling Market size in North America is estimated to be worth USD 994.64 million by 2027 from USD 670.7 million in 2022, growing at a CAGR of 8.20% during the forecast period.

The North American Nucleic Acid Labelling Market is expected to be driven by introducing advanced products offering pertain nucleic acid detection and penetration of nucleic acid labels to set witness elevation across DNA Microarrays. Also, expanding pool of commercial manufacturers strengthens the revenue generation capacity of the nucleic acid labelling industry. 

Recent developments in the nanotechnology sector have substantially improved nucleic acid detection at the point of care (POC). POC solutions might be used to detect RNA and DNA in a portable format; for example, this makes it appealing to individuals working in various healthcare fields, including on-site detection and bedside/patient side diagnosis. Reviewing recent developments targeted at examining the utilization of read-out modalities, sample preparation, and target amplification are examples of research initiatives along these lines. As a result of the introduction of innovative nanotechnology technologies, point-of-care nucleic acid detection is expected to acquire significant momentum inaccessible and decentralized testing, propelling the market forward. 

In the life sciences sector, nucleic acid tagging methods have a wide range of uses. Using different labelling techniques, nucleic acid labelling is primarily used to identify proteins, DNA, and RNA. Multiple labels for specific applications are currently available on the market.

The key to identifying individual compounds is to use the right labelling technique strategy. Previously, radioactive labelling techniques dominated the market. Radioactive methods, on the other hand, are less popular due to safety concerns. As a result of its great sensitivity and safety concerns, non-radioactive labelling methods are gaining popularity for accurately identifying molecules.

On the other hand, increasing healthcare expenditure, availability of healthcare infrastructure, and surging demand for personalized healthcare are rapidly increasing the market growth. In addition, the major companies in the region are conducting research and development activities on genomics, and the rise in disease diagnosis is driving the market growth. 

Chemiluminescent and chemifluorescent methods have replaced the use of radioactive materials to identify antibodies in the non-radioactive category. Several firms are focusing on developing nucleic acid labelling test kits for a variety of applications. Major diagnostic firms are designing nucleic acid test kits. The significant firms dominate the nucleic acid labelling market, with medium and small players coming in second and fourth.

However, the lack of skilled professionals in the transcriptomics field and expensive processing techniques restrict the North American nucleic acid labelling market growth. 

This research report on the North America Nucleic Acid Labelling Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Reagents and Kits
  • Services

By Labelling Technique: 

  • PCR
  • Nick Translation
  • Random Primer
  • In-Vitro Transcription
  • Reverse Transcription

By Application: 

  • DNA Sequencing
  • PCR
  • Fluorescence in Situ Hybridization (FISH)
  • Microarrays
  • Blotting
  • In-Situ Hybridization

By End Users: 

  • Diagnostic Centres
  • Research Centres
  • Hospitals

By Country: 

  • The United States
  • Canada
  • Rest of North America

Geographically, North America dominated the global Nucleic Acid Labelling Market and is likely to continue its dominance throughout the forecast period. The market in the region is mostly driven by technological advancements in the healthcare sector, favorable reimbursement policies, and growing concern among the people about healthcare. Also, with the healthcare spending, increasing research activities in genomics research and disease diagnosis are the other major growth factors influencing the market. As a result, the countries such as the United States and Canada are expanding the market with significant market share. Over the forecast period, the United States accounted substantial share in the market. The nucleic acid labelling market’s revenue-generating capability is strengthened by introducing improved product offerings in nucleic acid detection and the growing pool of commercial manufacturers. Moreover, considering the rising prevalence of genetic disorders, healthcare professionals are keen on investing in developing products related to nucleic acid analytics, which is expected to expand the market growth in the U.S. 

On the other hand, the Canadian Nucleic Acid Labelling Market is projected to witness a moderate market share and contribute to the regional market expansion. 

KEY MARKET PLAYERS:

A few of the prominent companies dominating the North America Nucleic Acid Labelling Market include Thermo Fisher Scientific, New England Biolabs, PerkinElmer, F. Hoffmann La-Roche AG, General Electric Company, Merck KGaA, Enzo Biochem, Promega Corporation, Vector Laboratories, and Agilent Technologies.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Reagents and Kits                

                                                5.1.2.1 Labels    

                                                                5.1.2.1.1 Radioactive Labels

                                                                5.1.2.1.2 Non-Radioactive Labels

                                                5.1.2.2 Probes  

                                                                5.1.2.2.1 Radioactive Probes

                                                                5.1.2.2.2 Non-Radioactive Probes

                                5.1.3 Services                    

                                5.1.4  Y-o-Y Growth Analysis, By Product                              

                                5.1.5  Market Attractiveness Analysis, By Product                            

                                5.1.6  Market Share Analysis, By Product                              

                5.2 Labelling Technique                                

                                5.2.1 Introduction                           

                                5.2.2 PCR                            

                                5.2.3 Nick Translation                    

                                5.2.4 Random Primer                     

                                5.2.5 In-Vitro Transcription                         

                                5.2.6 Reverse Transcription                        

                                5.2.7 End Labelling                          

                                5.2.8 Y-o-Y Growth Analysis, By Labelling Technique                       

                                5.2.9 Market Attractiveness Analysis, By Labelling Technique                     

                                5.2.10 Market Share Analysis, By Labelling Technique                     

                5.3 Application                                 

                                5.3.1 Introduction                           

                                5.3.2 DNA Sequencing                  

                                5.3.3 Polymerase Chain Reaction                             

                                5.3.4 Fluorescence in Situ Hybridization (FISH)                   

                                5.3.5 Microarrays                            

                                5.3.6 Blotting                     

                                5.3.7 In-Situ Hybridization                           

                                5.3.8 Other Applications                               

                                5.3.9 Y-o-Y Growth Analysis, By Application                         

                                5.3.10  Market Attractiveness Analysis, By Application                   

                                5.3.11  Market Share Analysis, By Application                     

                5.4 End-Users                                   

                                5.4.1 Introduction                           

                                5.4.2 Diagnostic Centres                               

                                5.4.3 Research Centres                 

                                5.4.4 Hospitals                  

                                5.4.5 Y-o-Y Growth Analysis, By End-Users                          

                                5.4.6  Market Attractiveness Analysis, By End-Users                       

                                5.4.7  Market Share Analysis, By End-Users                         

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Labelling Technique   

                                                6.1.3.4 By Application    

                                                6.1.3.5 By End-Users      

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Labelling Technique   

                                                6.1.4.4 By Application    

                                                6.1.4.5 By End-Users      

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Labelling Technique   

                                                6.1.5.4 By Application    

                                                6.1.5.5 By End-Users      

                6.2 United States                                            

                6.3 Canada                                         

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Thermo Fisher Scientific                                        

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 New England Biolabs                                              

                8.3 PerkinElmer                                               

                8.4 F.Hoffmann La-Roche AG                                     

                8.5 General Electric Company                                    

                8.6 Merck KGaA                                               

                8.7 Enzo Biochem                                            

                8.8 Promega Corporation                                            

                8.9 Vector Laboratories                                

                8.10 Agilent Technologies                                            

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. North America Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  2. North America Reagents & Kits Market, By Region, From 2022 - 2027 (USD Million)
  3. North America Services Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  5. North America PCR Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Nick Translation Market, By Region, From 2022 - 2027 (USD Million)
  7. North America Random Primer Market, By Region, From 2022 - 2027 (USD Million)
  8. North America In-Vitro Transcription Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Reverse Transcription Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  11. North America DNA Sequencing Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Polymerase Chain Reactions Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Fluorescence in Situ Hybridization (FISH) Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Microarrays Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Blotting Market, By Region, From 2022 - 2027 (USD Million)
  16. North America In-Situ Hybridization Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)
  18. North America Diagnostic Centres Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Research Centres Market, By Region, From 2022 - 2027 (USD Million)
  20. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  21. United States Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  22. United States Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  23. United States Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  24. United States Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)
  25. Canada Nucleic Acid Labelling Market, By Products, From 2022 - 2027 (USD Million)
  26. Canada Nucleic Acid Labelling Market, By Labelling Technique, From 2022 - 2027 (USD Million)
  27. Canada Nucleic Acid Labelling Market, By Application, From 2022 - 2027 (USD Million)
  28. Canada Nucleic Acid Labelling Market, By End-Users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample